VEGFA was identified as an activated UPR in CPA-treated GL261(B6) tumors (Additional file 4: Table S3A), consistent with the requirement for VEGFA signaling via VEGFR2 for CPA/6d to induce immune cell recruitment in responding gliomas [16, 19]. The gene discussed is KDR; the disease is central nervous system cancer.